Login
Israel-Hamas Conflict
Independence Day
Floods
World Cup
Natural Disasters
Social Media
South America
Real Madrid
Artificial Intelligence
Soccer
Donald Trump
BRICS
Parade
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

pharmtech.com image

News from pharmtech.com

We’ve assigned a media bias rating of Center to pharmtech.com. You can read more about our methodology here.
If you want to know if pharmtech.com is credible or reliable, look no further. We rank pharmtech.com as High factuality. Find out more about our methodology here.

Information about pharmtech.com

Where is pharmtech.com located?pharmtech.com's Website

Media Bias Ratings

Average Bias Rating:
Center
Center
byAd Fontes Media
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmtech.com News

Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia
Slovenia · Slovenia

Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia

Coverage: 2 sources
The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.See the Story
Generic Drugmaker Hikma Pledges $1bn in US Investment
Innovation · United States

Generic Drugmaker Hikma Pledges $1bn in US Investment

100% Center coverage: 2 sources
With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.See the Story
Siemens Finalizes $5.1B Dotmatics Acquisition

Siemens Finalizes $5.1B Dotmatics Acquisition

100% Center coverage: 1 sources
Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, and manufacturing digitally.See the Story

Piramal Pharma Holds Groundbreaking at Kentucky Facility, Part of $90 Million Investment Plan

100% Center coverage: 1 sources
The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.United States · United StatesSee the Story

A Novel, Enhanced, and Sustainable Approach to Audit Trail Review

100% Center coverage: 1 sources
Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.Eli Lilly · IndianapolisRead Article

Advanced Solutions for Sustained Delivery of Ocular Therapies

100% Center coverage: 1 sources
Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise.Read Article

Key Leaders at BIO 2025 Respond to Continuing Political Shifts

100% Center coverage: 1 sources
In contrast to earlier conferences in 2025, experts interviewed as part of the BIO conference in Boston did not come to a consensus about lasting impacts of recent changes in US government policy.Boston, Massachusetts · BostonRead Article

ten23 health Joins Gerresheimer, SCHOTT, Stevanato Group in ‘Alliance for RTU’

100% Center coverage: 1 sources
The partnership was formed in September 2024 in response to increasing demand for aseptic filling technologies and processes.HealthRead Article

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

100% Center coverage: 1 sources
The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.Latina · LatinaRead Article

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments

100% Center coverage: 1 sources
The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.Read Article

Ask the Expert: Adventitious Contamination Control

100% Center coverage: 1 sources
In this episode of the Ask the Expert video series, Simona Guidi, Associate Director, Cell and Gene Therapies at ProPharma, discusses the options available for controlling adventitious contamination in cell processing and the use of closed processing systems for cell therapy production.Read Article

Breaking News Topics Related to pharmtech.com

Innovation icon

Innovation

United States icon

United States

Medical icon

Medical

Health icon

Health

Pharma icon

Pharma

Artificial Intelligence icon

Artificial Intelligence

News
For You
SearchBlindspotLocal